Appus is natural
protein/peptide animal tissue extract at preclinical stage of development with
a following data:
- non-clinical
safety studies: positive acute toxicity evaluation on rats with 50x time
overdosing
- hypothetical
mechanism of action: IL
-10 up regulation by factor x10 and TNF -alpha level downregulation by 40-50% at
ex vivo induced human PBMC cells.
- Indications:
- over
40% reduction of pathological score at collagen induced mouse model of RA
- positive,
anecdotal observations at MS and ALS volunteers (delivery per os).
- >90%
efficacy at pilot clinical trials at dogs Pyometra treatment.